2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Toxicity: new trials by email Literature Review of Toxicity trials Research Report on Toxicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer bevacizumab - Toxicity | Phase 1 | Terminated | Amsterdam UMC, location VUmc | 6 | 2007-10-01 | 2011-04-05 |
| MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC) Manganese Superoxide Dismutase Plasmid Liposome, carboplatin, paclitaxel - Esophageal, Toxicity | Phase 1 / Phase 2 | Terminated | Joel Greenberger | 18 | 2005-11-11 | 2021-11-12 |
Lung Neoplasms (1) · Radiation Injuries (1)
Lung Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1) · Wounds and Injuries (1)
Bevacizumab (1) · Carboplatin (1) · Paclitaxel (1) · Radiotherapy (1)
Amsterdam UMC, location VUmc (1) · Joel Greenberger (1)
Netherlands (1) · United States (1)
Egbert F Smit, MD, PhD (1) · Joel Greenberger, MD (1) · Suresh Senan, MD, PhD (1)